Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Anika Therapeutics Inc ANIK

Healthcare Biotechnology
Anika Therapeutics, Inc. is a joint preservation company focused on developing, manufacturing, and commercializing products based on hyaluronic acid (HA) technology platform. The OA Pain Management product family consists of Monovisc and Orthovisc that provides pain relief from osteoarthritis conditions and Cingal consisting of its cross-linked HA material combined with a fast-acting steroid... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:ANIK)

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

GlobeNewswire 10 hours ago

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire April 2, 2024

Anika Reports Fourth Quarter and Year-End 2023 Financial Results

GlobeNewswire March 13, 2024

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire March 8, 2024

Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

GlobeNewswire February 27, 2024

Anika Highlights Its Recently Launched Integrity(TM) Implant System and RevoMotion(TM) Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting

GlobeNewswire February 13, 2024

Anika Announces First Surgeries Performed using the Integrity(TM) Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release

GlobeNewswire November 28, 2023

Anika to Participate in Upcoming Investor Conferences

GlobeNewswire November 7, 2023

Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the Business

GlobeNewswire November 2, 2023
View More News ››

Opinion & Analysis (NDAQ:ANIK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:ANIK)

Facial Injectables Market Share, Size, Report Analysis 2026

According to the latest report by IMARC Group, titled “Facial Injectables Market: Global Industry Trends, Share, Size, Growth...
zayaroy18 - June 9, 2021

RE: Potential w/ U.S. approval of ORTHOVISC

http://www.anikatherapeutics.com/prodset.htm
wwwallstocktalkcom - August 24, 2001

Potential w/ U.S. approval of ORTHOVISC

http://www.anikatherapeutics.com/
wwwallstocktalkcom - August 24, 2001

Approved for use in the United States

When will approval of ORTHOVISC be completed? A highly purified, high molecular weight, high viscosity injectable form of hyaluronic...
wwwallstocktalkcom - August 24, 2001

Approved for use in the United States

When will approval of ORTHOVISC be completed? A highly purified, high molecular weight, high viscosity injectable form of hyaluronic...
wwwallstocktalkcom - August 24, 2001

Self Funded through cash flow

The strongest feature the company has to offer is that it has been funded from its base of operations that have brought a solid cash flow...
Fugative - October 17, 1999
View more Bullboard ››

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ...
View More »